75 related articles for article (PubMed ID: 18205217)
1. Isolation and functional analysis of five HPVE6 variants with respect to p53 degradation.
Hiller T; Stubenrauch F; Iftner T
J Med Virol; 2008 Mar; 80(3):478-83. PubMed ID: 18205217
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
[TBL] [Abstract][Full Text] [Related]
3. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6.
Lichtig H; Algrisi M; Botzer LE; Abadi T; Verbitzky Y; Jackman A; Tommasino M; Zehbe I; Sherman L
Virology; 2006 Jun; 350(1):216-27. PubMed ID: 16519914
[TBL] [Abstract][Full Text] [Related]
4. The role of TP53 in Cervical carcinogenesis.
Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I
Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117
[TBL] [Abstract][Full Text] [Related]
5. Activities of human papillomavirus 16 E6 natural variants in human keratinocytes.
Asadurian Y; Kurilin H; Lichtig H; Jackman A; Gonen P; Tommasino M; Zehbe I; Sherman L
J Med Virol; 2007 Nov; 79(11):1751-60. PubMed ID: 17854024
[TBL] [Abstract][Full Text] [Related]
6. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
7. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
[TBL] [Abstract][Full Text] [Related]
8. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
9. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
[TBL] [Abstract][Full Text] [Related]
10. HPV6 variants from malignant tumors with sequence alterations in the regulatory region do not reveal differences in the activities of the oncogene promoters but do contain amino acid exchanges in the E6 and E7 proteins.
Grassmann K; Wilczynski SP; Cook N; Rapp B; Iftner T
Virology; 1996 Sep; 223(1):185-97. PubMed ID: 8806552
[TBL] [Abstract][Full Text] [Related]
11. Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology.
Cento V; Rahmatalla N; Ciccozzi M; Perno CF; Ciotti M
J Med Virol; 2011 Oct; 83(10):1752-61. PubMed ID: 21837791
[TBL] [Abstract][Full Text] [Related]
12. p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.
Mesplède T; Gagnon D; Bergeron-Labrecque F; Azar I; Sénéchal H; Coutlée F; Archambault J
J Virol; 2012 Jan; 86(1):94-107. PubMed ID: 22013048
[TBL] [Abstract][Full Text] [Related]
13. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
Uversky VN; Roman A; Oldfield CJ; Dunker AK
J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
[TBL] [Abstract][Full Text] [Related]
14. Genetic variability in E6, E7 and L1 protein of HPV81 from HIV-1 positive women in Italy.
Minosse C; Garbuglia AR; Lapa D; Sias C; Zaniratti MS; Capobianchi MR
New Microbiol; 2010 Jan; 33(1):25-35. PubMed ID: 20402411
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression.
Lee K; Magalhaes I; Clavel C; Briolat J; Birembaut P; Tommasino M; Zehbe I
Virus Res; 2008 Jan; 131(1):106-10. PubMed ID: 17869365
[TBL] [Abstract][Full Text] [Related]
16. Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity.
Fu L; Van Doorslaer K; Chen Z; Ristriani T; Masson M; Travé G; Burk RD
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862247
[TBL] [Abstract][Full Text] [Related]
17. Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
Hampson L; Kitchener HC; Hampson IN
Antivir Ther; 2006; 11(6):813-25. PubMed ID: 17310826
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 variants in cervical cancer from an admixtured population in Brazil.
Junes-Gill K; Sichero L; Maciag PC; Mello W; Noronha V; Villa LL
J Med Virol; 2008 Sep; 80(9):1639-45. PubMed ID: 18649325
[TBL] [Abstract][Full Text] [Related]
20. Genetic variability and phylogeny of the high-risk HPV-31, -33, -35, -52, and -58 in central Brazil.
Raiol T; Wyant PS; de Amorim RM; Cerqueira DM; Milanezi Nv; Brígido Mde M; Sichero L; Martins CR
J Med Virol; 2009 Apr; 81(4):685-92. PubMed ID: 19235839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
